← All patents

US20110189095A1

Crkl targeting peptides

University of Texas System

Abstract

Provided are methods and compositions for selectively targeting CRKL through the use of targeting peptides. Selective targeting of secreted CRKL through the use of a targeting peptide may be used, for example, in the treatment of cancer to deliver a chemotherapeutic compound, fusion protein, or …

University
University of Texas System
Assignee
The Board Of Regents, Of The University Of Texas System
Inventor
Wadih Arap
Priority date
June 20, 2008
Filing date
June 19, 2009
Publication date
August 04, 2011
Language
en
Metadata fetched
August 29, 2026 00:20